The role of serotonin in reward, punishment and behavioural inhibition in humans: Insights from studies with acute tryptophan depletion

Neuroscience and Biobehavioral Reviews

Volumn 46, Issue P3, 2014, Pages 365-378

  Faulkner, Paul ^a   Deakin, J F William ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neuroscience and Psychiatry Unit   (United Kingdom)

Author keywords

5 HT; Aversion; Behavioural inhibition; Learning; Punishment; Raphe nucleus; Reward; Serotonin; Tryptophan depletion

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ACUTE TRYPTOPHAN DEPLETION; AMINO ACID DEFICIENCY; ATTENTION DEFICIT DISORDER; AVERSIVE BEHAVIOR; BOLD SIGNAL; COPING BEHAVIOR; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGH RISK BEHAVIOR; HUMAN; INHIBITION (PSYCHOLOGY); MENTAL TASK; PATHOLOGICAL GAMBLING; PUNISHMENT; REINFORCEMENT; RESPONSE TIME; REVIEW; REWARD; SEROTONIN RELEASE; SYSTEMATIC REVIEW; TASK PERFORMANCE; DEFICIENCY; MEDLINE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

HUMANS; INHIBITION (PSYCHOLOGY); PUBMED; PUNISHMENT; REWARD; TRYPTOPHAN;

EID: 84911391632     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.07.024     Document Type: Review

References (103)

1. Anderson I.M., Richell R.A., Bradshaw C.M. The effect of acute tryptophan depletion on probabilistic choice. J. Psychopharmacol. (Oxf.) 2003, 17:3-7.
2. Angoa-Perez M., Kane M.J., Briggs D.I., Sykes C.E., Shah M.M., Francescutti D.M., Rosenberg D.R., Thomas D.M., Kuhn D.M. Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J. Neurochem. 2012, 121:974-984.
3. Bizot J.C., Thiébot M.H., Le Bihan C., Soubrié P., Simon P. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. J. Pharmacol. Exp. Ther. 1988, 246:1144-1151.
4. Boureau Y.-L., Dayan P. Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 2011, 36:74-97.
5. Bromberg-Martin E.S., Hikosaka O., Nakamura K. Coding of task reward value in the dorsal raphe nucleus. J. Neurosci. 2010, 30:6262-6272.
6. Campbell-Meiklejohn D., Wakeley J., Herbert V., Cook J., Scollo P., Ray M.K., Selvaraj S., Passingham R.E., Cowen P., Rogers R.D. Serotonin and dopamine play complementary roles in gambling to recover losses. Neuropsychopharmacology 2011, 36:402-410.
7. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl.) 2005, 182:570-578.
8. Clark L., Robbins T.W., Ersche K.D., Sahakian B.J. Reflection impulsivity in current and former substance users. Biol. Psychiatry 2006, 60:515-522.
9. Clark L., Dombrovski A.Y., Siegle G.J., Butters M.A., Shollenberger C.L., Sahakian B.J., Szanto K. Impairment in risk-sensitive decision-making in older suicide attempters with depression. Psychol. Aging 2011, 26:321-330.
10. Cools R., Blackwell A., Clark L., Menzies L., Cox S., Robbins T.W. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 2005, 30:1362-1373.
11. Cools R., Robinson O.J., Sahakian B. Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology 2008, 33:2291-2299.
12. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
13. Cools R., Nakamura K., Daw N.D. Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology 2011, 36:98-113.
14. Crean J., Richards J.B., de Wit H. Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav. Brain Res. 2002, 136:349-357.
15. Crockett M.J., Clark L., Robbins T.W. Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J. Neurosci. 2009, 29:11993-11999.
16. Crockett M.J., Clark L., Roiser J.P., Robinson O.J., Cools R., Chase H.W., Ouden H.D., Apergis-Schoute A., Campbell-Meiklejohn D., Seymour B., Sahakian B.J., Rogers R.D., Robbins T.W. Converging evidence for central 5-HT effects in acute tryptophan depletion. Mol. Psychiatry 2012, 17:121-123.
17. Crockett M.J., Clark L., Apergis-Schoute A.M., Morein-Zamir S., Robbins T.W. Serotonin modulates the effects of Pavlovian aversive predictions on response vigor. Neuropsychopharmacology 2012, 37:2244-2252.
18. Crockett M.J., Clark L., Smillie L.D., Robbins T.W. The effects of acute tryptophan depletion on costly information sampling: impulsivity or aversive processing?. Psychopharmacology (Berl.) 2012, 219:587-597.
19. Dalley J.W., Roiser J.P. Dopamine, serotonin and impulsivity. Neuroscience 2012, 215:42-58.
20. Daw N.D., Kakade S., Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002, 15:603-616.
21. Dayan P., Huys Q.J.M. Serotonin, inhibition, and negative mood. PLoS Comput. Biol. 2008, 4:e4.
22. Deakin J.F.W. Roles of serotonergic systems in escape, avoidance and other behaviours. Theories in Psychopharmacology 1983, 179-204. Academic Press, London/New York. S. Cooper (Ed.).
23. Deakin J.F. 5-HT, antidepressant drugs and the psychosocial origins of depression. J. Psychopharmacol. 1996, 10:31-38.
24. Deakin J.F. Depression and antisocial personality disorders: two contrasting disorders of 5HT function. J. Neural Transm. Suppl. 2003, 64:79-93.
25. Deakin J.F. The origins of '5-HT and mechanisms of defence' by Deakin and Graeff: a personal perspective. J. Psychopharmacol. 2013, 27:1084-1089.
26. Deakin J.F., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. 1991, 5:305-315.
27. Demoto Y., Okada G., Okamoto Y., Kunisato Y., Aoyama S., Onoda K., Munakata A., Nomura M., Tanaka S.C., Schweighofer N., Doya K., Yamawaki S. Neural and personality correlates of individual differences related to the effects of acute tryptophan depletion on future reward evaluation. Neuropsychobiology 2012, 65:55-64.
28. den Ouden H.E.M., Daw N.D., Fernandez G., Elshout J.A., Rijpkema M., Hoogman M., Franke B., Cools R. Dissociable effects of dopamine and serotonin on reversal learning. Neuron 2013, 80:1090-1100.
29. Doya K. Metalearning and neuromodulation. Neural Netw. 2002, 15:495-506.
30. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl.) 2008, 199:439-456.
31. Eagle D.M., Lehmann O., Theobald D.E., Pena Y., Zakaria R., Ghosh R., Dalley J.W., Robbins T.W. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacol 2009, 34:1311-1321.
32. Eagle D.M., Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci. Biobehav. Rev. 2010, 34:50-72.
33. Elliott R., Zahn R., Deakin J.F., Anderson I.M. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 2011, 36:153-182.
34. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl.) 1999, 146:348-361.
35. Evers E.A.T., Cools R., Clark L., van der Veen F.M., Jolles J., Sahakian B.J., Robbins T.W. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 2005, 30:1138-1147.
36. Evers E.A.T., van der Veen F.M., van Deursen J.A., Schmitt J.A.J., Deutz N.E.P., Jolles J. The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers. Psychopharmacology (Berl.) 2006, 187:200-208.
37. Finger E.C., Marsh A.A., Buzas B., Kamel N., Rhodes R., Vythilingham M., Pine D.S., Goldman D., Blair J.R. The impact of tryptophan depletion and 5-HTTLPR genotype on passive avoidance and response reversal instrumental learning tasks. Neuropsychopharmacology 2007, 32:206-215.
38. Forster G.L., Feng N., Watt M.J., Korzan W.J., Mouw N.J., Summers C.H., Renner K.J. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behaviour. Neuroscience 2006, 141:1047-1055.
39. Forster G.L., Pringle R.B., Mouw N.J., Vuong S.M., Watt M.J., Burke A.R., Lowry C.A., Summers C.H., Renner K.J. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur. J. Neurosci. 2008, 28:299-310.
40. Geurts D.E.M., Huys Q.J.M., den Ouden H.E.M., Cools R. Serotonin and aversive Pavlovian control of instrumental behavior in humans. J. Neurosci. 2013, 33:18932-18939.
41. Graeff F.G., Del-Ben C.M. Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci. Biobehav. Rev. 2008, 32:1326-1335.
42. Graeff F.G., Schoenfeld R.I. Tryptaminergic mechanisms in punished and nonpunished behavior. J. Pharmacol. Exp. Ther. 1970, 173:277-283.
43. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl.) 1997, 133:329-342.
44. Harrison A.A., Everitt B.J., Robbins T.W. Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav. Brain Res. 1997, 89:135-149.
45. Harrison A.A., Everitt B.J., Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav. Brain Res. 1999, 100:99-112.
46. Harvey J.A., Schlosberg A.J., Yunger L.M. Behavioral correlates of serotonin depletion. Fed. Proc. 1975, 34:1796-1801.
47. Hindi Attar C., Finckh B., Büchel C. The influence of serotonin on fear learning. PLoS ONE 2012, 7:e42397.
48. Kagan J. Reflection-impulsivity: the generality and dynamics of conceptual tempo. J. Abnorm. Psychol. 1966, 71:17-24.
49. LeMarquand D.G., Pihl R.O., Young S.N., Tremblay R.E., Séguin J.R., Palmour R.M., Benkelfat C. Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology 1998, 19:333-341.
50. LeMarquand D.G., Benkelfat C., Pihl R.O., Palmour R.M., Young S.N. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am. J. Psychiatry 1999, 156:1771-1779.
51. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sci. 1983, 33:2609-2614.
52. Lowry C.A. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 2002, 14:911-923.
53. Macoveanu J., Hornboll B., Elliott R., Erritzoe D., Paulson O.B., Siebner H., Knudsen G.M., Rowe J.B. Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology 2013, 38:996-1005.
54. Macoveanu J., Rowe J.B., Hornboll B., Elliott R., Paulson O.B., Knudsen G.M., Siebner H.R. Playing it safe but losing anyway - serotonergic signalling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion. Eur. Neuropsychopharmacol. 2013, 23:919-930.
55. Maier S.F., Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 2005, 29:829-841.
56. Mazur J.E., Vaughan W. Molar optimization versus delayed reinforcement as explanations of choice between fixed-ratio and progressive-ratio schedules. J. Exp. Anal. Behav. 1987, 48:251-261.
57. McNaughton N., Corr P.J. A two-dimensional view of defensive systems: defensive distance and fear/anxiety. Neurosci. Biobehav. Rev. 2004, 28:285-305.
58. McNaughton N., Swart C., Neo P.S.H., Bates V., Glue P. Anti-anxiety drugs reduce conflict-specific "theta" - a possible human anxiety-specific biomarker. J. Affect. Disorders 2013, 148:104-111.
59. Mendelsohn D., Riedel W.J., Sambeth A. Effects of acute tryptophan depletion on memory, attention and executive functions: a systematic review. Neurosci. Biobehav. Rev. 2009, 33:926-952.
60. Miyazaki K., Miyazaki K.W., Doya K. The role of serotonin in the regulation of patience and impulsivity. Mol. Neurobiol. 2012, 45:213-224.
61. 2-induced anxiety in patients with panic disorder and normal volunteers. Br. J. Psychiatry. 2000, 176:182-188.
62. Mobbs D., Petrovic P., Marchant J.L., Hassabis D., Weiskopf N., Seymour B., Dolan R.J., Frith C.D. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007, 317:1079-1083.
63. Mortimore C., Anderson I.M. d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine. Psychopharmacology (Berl). 2000, 149:251-258.
64. Mobini S., Chiang T.J., Al-Ruwaitea A.S., Ho M.Y., Bradshaw C.M., Szabadi E. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl.) 2000, 149:313-318.
65. Murphy F.C., Smith K.A., Cowen P.J., Robbins T.W., Sahakian B.J. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl.) 2002, 163:42-53.
66. Paul E.D., Lowry C.A. Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J. Psychopharmacol. 2013, 27:1090-1106.
67. Paul E.D., Johnson P.L., Shekhar A., Lowry C.A. The Deakin/Graeff hypothesis: Focus on serotonergic inhibition of panic. Neurosci. Biobehav. Rev. 2014, [Epub ahead of print].
68. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
69. Pine A., Seymour B., Roiser J.P., Bossaerts P., Friston K.J., Curran H.V., Dolan R.J. Encoding of marginal utility across time in the human brain. J. Neurosci. 2009, 29:9575-9581.
70. Roberts A.C. The importance of serotonin for orbitofrontal function. Biol. Psychiatry 2011, 69:1185-1191.
71. Robinson O.J., Cools R., Crockett M.J., Sahakian B.J. Mood state moderates the role of serotonin in cognitive biases. J. Psychopharmacol. 2010, 24:573-583.
72. Robinson O.J., Cools R., Sahakian B.J. Tryptophan depletion disinhibits punishment but not reward prediction: implications for resilience. Psychopharmacology (Berl.) 2012, 219:599-605.
73. Robinson O.J., Overstreet C., Allen P.S., Letkiewicz A., Vytal K., Pine D.S., Grillon C. The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala 'aversive amplification' circuit. Neuroimage 2013, 78:217-223.
74. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C., Nestler E.J., Hen R. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 1998, 393:175-178.
75. Rogers R.D., Blackshaw A.J., Middleton H.C., Matthews K., Hawtin K., Crowley C., Hopwood A., Wallace C., Deakin J.F., Sahakian B.J., Robbins T.W. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl.) 1999, 146:482-491.
76. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F., Sahakian B.J., Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999, 20:322-339.
77. Rogers R.D., Tunbridge E.M., Bhagwagar Z., Drevets W.C., Sahakian B.J., Carter C.S. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 2003, 28:153-162.
78. Roiser J.P., Blackwell A.D., Cools R., Clark L., Rubinsztein D.C., Robbins T.W., Sahakian B.J. Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 2006, 31:2264-2272.
79. Roiser J.P., Elliott R., Sahakian B.J. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 2012, 37:117-136.
80. Rosvold H.E., Delgado J.M. The effect on delayed-alternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey's brain. J. Comp. Physiol. Psychol. 1956, 49:365-372.
81. Rubia K., Lee F., Cleare A.J., Tunstall N., Fu C.H.Y., Brammer M., McGuire P. Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl.) 2005, 179:791-803.
82. Rylands A.J., Hinz R., Jones M., Holmes S.E., Feldmann M., Brown G., McMahon A.W., Talbot P.S. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907. Biol. Psychiatry 2013, 72:1004-1011.
83. Sahakian B.J., Owen A.M. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. R. Soc. Med. 1992, 85:399-402.
84. Salomon R.M., Cowan R.L., Rogers B.P., Dietrich M.S., Bauernfeind A.L., Kessler R.M., Gore J.C. Time series fMRI measures detect changes in pontine raphe following acute tryptophan depletion. Psychiatry Res. 2011, 191:112-121.
85. Schütz M.T., de Aguiar J.C., Graeff F.G. Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology (Berl.) 1985, 85:340-345.
86. Schultz W., Dayan P., Montague P.R.A. Neural substrate of prediction and reward. Science 1997, 275:1593-1599.
87. Schweighofer N., Bertin M., Shishida K., Okamoto Y., Tanaka S.C., Yamawaki S., Doya K. Low-serotonin levels increase delayed reward discounting in humans. J. Neurosci. 2008, 28:4528-4532.
88. Seymour B., Daw N.D., Roiser J.P., Dayan P., Dolan R. Serotonin selectively modulates reward value in human decision-making. J. Neurosci. 2012, 32:5833-5842.
89. Soubrié P. Serotonergic neurons and behavior. J. Pharmacol. 1986, 17:107-112.
90. Talbot P.S., Watson D.R., Barrett S.L., Cooper S.J. Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting. Neuropsychopharmacology 2006, 31:1519-1525.
91. Tanaka S.C., Doya K., Okada G., Ueda K., Okamoto Y., Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat. Neurosci. 2004, 7:887-893.
92. Tanaka S.C., Schweighofer N., Asahi S., Shishida K., Okamoto Y., Yamawaki S., Doya K. Serotonin differentially regulates short- and long-term prediction of rewards in the ventral and dorsal striatum. PLoS ONE 2007, 2:e1333.
93. Tanaka S.C., Shishida K., Schweighofer N., Okamoto Y., Yamawaki S., Doya K. Serotonin affects association of aversive outcomes to past actions. J. Neurosci. 2009, 29:15669-15674.
94. Tuescher O., Protopopescu X., Pan H., Cloitre M., Butler T., Goldstein M., Root J.C., Engelien A., Furman D., Silverman M., Yang Y., Gorman J.M., LeDoux J., Silbersweig D., Stern E. Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD. J. Anxiety Disord. 2011, 25:251-257.
95. van Donkelaar E.L., Blokland A., Ferrington L., Kelly P.A., Steinbusch H.W., Prickaerts J. Mechanism of acute tryptophan depletion: is it only serotonin?. Mol. Psychiatry 2011, 16:695-713.
96. Walderhaug E., Lunde H., Nordvik J.E., Landrø N.I., Refsum H., Magnusson A. Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl.) 2002, 164:385-391.
97. Walderhaug E., Landrø N.I., Magnusson A. A synergic effect between lowered serotonin and novel situations on impulsivity measured by CPT. J. Clin. Exp. Neuropsychol. 2008, 30:204-211.
98. Winstanley C.A., Dalley J.W., Theobald D.E.H., Robbins T.W. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 2004, 29:1331-1343.
99. Winstanley C.A., Eagle D.M., Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 2006, 26:379-395.
100. Wise C.D., Berger B.D., Stein L. Serotonin: a possible mediator of behavioural suppression induced by anxiety. Dis. Nerv. Syst. 1970, 31(Suppl.):34-37.
101. Worbe Y., Savulich G., Voon V., Fernandez-Egea E., Robbins T.W. Serotonin depletion induces 'waiting impulsivity' on the human four-choice serial reaction time task: cross-species translational significance. Neuropsychopharmacology 2014, (Epub ahead of print).
102. Yacubian J., Gläscher J., Schroeder K., Sommer T., Braus D.F., Büchel C. Dissociable systems for gain- and loss-related value predictions and errors of prediction in the human brain. J. Neurosci. 2006, 26(37):9530-9537.
103. Zepf F.D., Holtmann M., Stadler C., Demisch L., Schmitt M., Wöckel L., Poustka F. Diminished serotonergic functioning in hostile children with ADHD: tryptophan depletion increases behavioural inhibition. Pharmacopsychiatry 2008, 41:60-65.